Clinical Trial Update: A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase I/II study of SENS-501 in children with otoferlin-related nonsyndromic hearing loss (DFNB9) due to OTOF mutatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Deafness
• Otoferlin-related Nonsyndromic Hearing Loss
• Sensorineural Hearing Loss

Drugs mentioned

• SENS-501

Snippet

Sponsor: Sensorion | Conditions: OTOF Gene Mutation, DFNB9 | Phase 1, Phase 2 | Status: RECRUITING